PINK:BXPHF

Botanix Pharmaceuticals Stock Earnings Reports

etoro logo Buy BXPHF
*Your capital is at risk
$0.0241
+0 (+0%)
At Close: Jun 22, 2026

Botanix Pharmaceuticals Earnings Calls

Dec 31, 2025
-$0.0113 (-68.97%)
Release date Feb 26, 2026
EPS estimate -$0.0067
EPS actual -$0.0113
EPS Surprise -68.97%
Revenue estimate 11.01M
Revenue actual 11.01M
Revenue Surprise 0.0035%
Jun 30, 2025
-$0.0197 (-199.85%)
Release date Aug 29, 2025
EPS estimate -$0.0066
EPS actual -$0.0197
EPS Surprise -199.85%
Revenue estimate 2.186M
Revenue actual 3.554M
Revenue Surprise 62.56%
Dec 30, 2024
-$0.0105 (-1,796.77%)
Release date Apr 24, 2025
EPS estimate $0.0006
EPS actual -$0.0105
EPS Surprise -1,796.77%
Revenue estimate 7.177M
Revenue actual 213.858K
Revenue Surprise -97.02%
Jun 30, 2024
Release date Aug 29, 2024
EPS estimate -
EPS actual -$0.0036
Revenue estimate -
Revenue actual 1.128M

Last 4 Quarters for Botanix Pharmaceuticals

Below you can see how BXPHF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Jun 30, 2024
Release date Aug 29, 2024
Price on release $0.250
EPS estimate -
EPS actual -$0.0036
Date Price
Aug 23, 2024 $0.250
Aug 26, 2024 $0.250
Aug 27, 2024 $0.250
Aug 28, 2024 $0.250
Aug 29, 2024 $0.250
Aug 30, 2024 $0.260
Sep 03, 2024 $0.350
Sep 04, 2024 $0.350
Sep 05, 2024 $0.340
4 days before 0%
4 days after 36.00%
On release day 4.00%
Change in period 36.00%
Dec 30, 2024 Missed
Release date Apr 24, 2025
Price on release $0.230
EPS estimate $0.0006
EPS actual -$0.0105
EPS surprise -1,796.77%
Date Price
Apr 18, 2025 $0.230
Apr 21, 2025 $0.230
Apr 22, 2025 $0.230
Apr 23, 2025 $0.230
Apr 24, 2025 $0.230
Apr 25, 2025 $0.230
Apr 28, 2025 $0.230
Apr 29, 2025 $0.230
Apr 30, 2025 $0.230
4 days before 0%
4 days after 0%
On release day 0%
Change in period 0%
Jun 30, 2025 Missed
Release date Aug 29, 2025
Price on release $0.100
EPS estimate -$0.0066
EPS actual -$0.0197
EPS surprise -199.85%
Date Price
Aug 25, 2025 $0.0935
Aug 26, 2025 $0.0935
Aug 27, 2025 $0.100
Aug 28, 2025 $0.102
Aug 29, 2025 $0.100
Sep 02, 2025 $0.100
Sep 03, 2025 $0.100
Sep 04, 2025 $0.100
Sep 05, 2025 $0.100
4 days before 6.95%
4 days after 0%
On release day 0%
Change in period 6.95%
Dec 31, 2025 Missed
Release date Feb 26, 2026
Price on release $0.0460
EPS estimate -$0.0067
EPS actual -$0.0113
EPS surprise -68.97%
Date Price
Feb 20, 2026 $0.0429
Feb 23, 2026 $0.0429
Feb 24, 2026 $0.0429
Feb 25, 2026 $0.0452
Feb 26, 2026 $0.0460
Feb 27, 2026 $0.0460
Mar 02, 2026 $0.0430
Mar 03, 2026 $0.0400
Mar 04, 2026 $0.0400
4 days before 7.23%
4 days after -13.04%
On release day 0%
Change in period -6.76%

Botanix Pharmaceuticals Earnings History

Earnings Calendar

FAQ

When is the earnings report for BXPHF?
Botanix Pharmaceuticals Limited (BXPHF) has scheduled its earnings report for Aug 28, 2026 before the markets open.

What is the BXPHF price-to-earnings (P/E) ratio?
BXPHF P/E ratio as of Jun 22, 2026 (TTM) is -0.452.

What is the BXPHF EPS forecast?
The forecasted EPS (Earnings Per Share) for Botanix Pharmaceuticals Limited (BXPHF) for the first fiscal quarter 2026 is -$0.0071.

What are Botanix Pharmaceuticals Limited's retained earnings?
On its balance sheet, Botanix Pharmaceuticals Limited reported retained earnings of $11.01 million for the latest quarter ending Dec 31, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE